See more : Raia Drogasil S.A. (RADL3.SA) Income Statement Analysis – Financial Results
Complete financial analysis of Waldencast plc (WALDW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Waldencast plc, a leading company in the Software – Application industry within the Technology sector.
- Verici Dx plc (VRCDF) Income Statement Analysis – Financial Results
- JPMorgan Chase & Co. (0Q1F.L) Income Statement Analysis – Financial Results
- Elkop SE (EKP.WA) Income Statement Analysis – Financial Results
- Asian Hotels (East) Limited (AHLEAST.BO) Income Statement Analysis – Financial Results
- Caledonia Investments plc (CALEF) Income Statement Analysis – Financial Results
Waldencast plc (WALDW)
About Waldencast plc
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 218.14M | 166.13M | 142.47M | 94.43M |
| Cost of Revenue | 76.56M | 126.70M | 55.04M | 29.10M |
| Gross Profit | 141.58M | 39.44M | 87.44M | 65.33M |
| Gross Profit Ratio | 64.90% | 23.74% | 61.37% | 69.19% |
| Research & Development | 3.20M | 4.40M | 6.09M | 4.38M |
| General & Administrative | 0.00 | 0.00 | 9.13M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 73.83M | 0.00 |
| SG&A | 220.31M | 109.30M | 82.97M | 60.42M |
| Other Expenses | 0.00 | 0.00 | 817.00K | -11.00K |
| Operating Expenses | 223.51M | 113.71M | 89.06M | 64.80M |
| Cost & Expenses | 300.07M | 240.40M | 144.10M | 93.90M |
| Interest Income | 0.00 | 12.88K | 53.19K | 0.00 |
| Interest Expense | 18.91M | 12.88M | 11.12M | 6.28M |
| Depreciation & Amortization | 60.50M | 35.17M | 13.90M | 13.42M |
| EBITDA | -33.54M | -99.25M | 15.05M | 13.94M |
| EBITDA Ratio | -15.38% | -23.53% | 9.19% | 14.76% |
| Operating Income | -81.93M | -74.27M | -1.63M | 528.00K |
| Operating Income Ratio | -37.56% | -44.70% | -1.14% | 0.56% |
| Total Other Income/Expenses | -31.01M | -4.32M | -8.35M | -6.29M |
| Income Before Tax | -112.94M | -147.30M | -9.97M | -5.76M |
| Income Before Tax Ratio | -51.78% | -88.67% | -7.00% | -6.10% |
| Income Tax Expense | -6.98M | -5.69M | 9.60M | -3.39M |
| Net Income | -89.98M | -116.62M | -19.58M | -2.37M |
| Net Income Ratio | -41.25% | -70.20% | -13.74% | -2.51% |
| EPS | -0.89 | -1.08 | -0.45 | -0.20 |
| EPS Diluted | -0.89 | -1.08 | -0.45 | -0.20 |
| Weighted Avg Shares Out | 101.23M | 107.56M | 43.71M | 11.68M |
| Weighted Avg Shares Out (Dil) | 101.23M | 107.56M | 43.71M | 11.68M |
Source: https://incomestatements.info
Category: Stock Reports